Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:35 pm Purchase | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | T. Rowe Price Associates, Inc. | 4,871,084 10.900% | 244,189 (+5.28%) | Filing History |
| 2022-02-11 4:34 pm Sale | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | COLUMN GROUP L P | 654,245 1.500% | -6,101,636 (-90.32%) | Filing History |
| 2022-02-11 3:11 pm Sale | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Foresite Capital Fund IV, L.P. | 1,205,798 2.700% | -2,045,051 (-62.91%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | BlackRock Inc. BLK | 2,547,861 5.700% | 2,547,861 (New Position) | Filing History |
| 2022-02-04 09:21 am Sale | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Wellington Management Group LLP | 1,162,316 2.610% | -1,285,268 (-52.51%) | Filing History |
| 2021-08-10 1:41 pm Purchase | 2021-07-31 | 13G | Nurix Therapeutics, Inc. NRIX | T. Rowe Price Associates, Inc. | 4,626,895 10.400% | 4,626,895 (New Position) | Filing History |
| 2021-02-16 4:15 pm Purchase | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 5,422,549 14.000% | 5,422,549 (New Position) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 2,846,125 7.300% | 2,846,125 (New Position) | Filing History |
| 2021-02-16 11:08 am Purchase | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Foresite Capital Fund IV, L.P. | 3,250,849 8.400% | 90,065 (+2.85%) | Filing History |
| 2021-02-12 6:16 pm Purchase | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | COLUMN GROUP L P | 6,755,881 17.400% | 6,755,881 (New Position) | Filing History |
| 2021-02-04 09:51 am Sale | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Wellington Management Group LLP | 2,447,584 6.300% | -1,628,396 (-39.95%) | Filing History |